| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.85e-06 | 44 | 93 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.15e-05 | 10 | 93 | 3 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.01e-05 | 71 | 93 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.70e-05 | 13 | 93 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.20e-04 | 103 | 93 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 2.13e-04 | 5 | 93 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.86e-04 | 68 | 93 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.02e-04 | 69 | 93 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 5.90e-04 | 8 | 93 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | calcium ion binding | FAT3 PCLO SPTAN1 PCDHB15 CAPN11 EHD4 FAT2 CDH22 CADPS TLL2 MACF1 | 7.14e-04 | 749 | 93 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.47e-03 | 105 | 93 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.62e-03 | 13 | 93 | 2 | GO:0046975 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 1.04e-06 | 17 | 97 | 4 | GO:0098962 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.30e-05 | 89 | 97 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 8.85e-05 | 223 | 97 | 7 | GO:0007519 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.10e-04 | 100 | 97 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.38e-04 | 105 | 97 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 1.40e-04 | 240 | 97 | 7 | GO:0060538 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.40e-04 | 56 | 97 | 4 | GO:0099601 | |
| GeneOntologyCellularComponent | Set3 complex | 2.13e-05 | 2 | 97 | 2 | GO:0034967 | |
| GeneOntologyCellularComponent | Rpd3L-Expanded complex | 2.13e-05 | 2 | 97 | 2 | GO:0070210 | |
| GeneOntologyCellularComponent | chromatin | SOX11 NSD2 ZBTB43 DVL3 SMARCAD1 XRCC1 KMT2E YY1 SUV39H2 PBRM1 UBR5 SETD5 BRD9 EHMT1 PHF14 TIMELESS PAX5 DMRT1 | 1.41e-04 | 1480 | 97 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.76e-04 | 112 | 97 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | cell cortex | 3.34e-04 | 371 | 97 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.39e-04 | 129 | 97 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 9.27e-04 | 93 | 97 | 4 | GO:0030864 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.19e-03 | 254 | 97 | 6 | GO:0000228 | |
| Domain | SAPAP | 3.13e-09 | 5 | 95 | 4 | IPR005026 | |
| Domain | GKAP | 3.13e-09 | 5 | 95 | 4 | PF03359 | |
| Domain | SET | 1.98e-06 | 41 | 95 | 5 | PF00856 | |
| Domain | SET | 3.56e-06 | 46 | 95 | 5 | SM00317 | |
| Domain | SET_dom | 5.41e-06 | 50 | 95 | 5 | IPR001214 | |
| Domain | SET | 5.41e-06 | 50 | 95 | 5 | PS50280 | |
| Domain | PDZ | 1.22e-04 | 151 | 95 | 6 | PS50106 | |
| Domain | PDZ | 1.26e-04 | 152 | 95 | 6 | IPR001478 | |
| Domain | - | 1.69e-04 | 391 | 95 | 9 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.19e-04 | 426 | 95 | 9 | IPR011993 | |
| Domain | PreSET | 5.29e-04 | 7 | 95 | 2 | SM00468 | |
| Domain | Pre-SET | 5.29e-04 | 7 | 95 | 2 | PF05033 | |
| Domain | Pre-SET_dom | 5.29e-04 | 7 | 95 | 2 | IPR007728 | |
| Domain | PRE_SET | 5.29e-04 | 7 | 95 | 2 | PS50867 | |
| Domain | Znf_FYVE_PHD | 9.26e-04 | 147 | 95 | 5 | IPR011011 | |
| Domain | - | 1.01e-03 | 150 | 95 | 5 | 2.30.42.10 | |
| Domain | Laminin_G_2 | 1.10e-03 | 40 | 95 | 3 | PF02210 | |
| Domain | PH | 1.12e-03 | 229 | 95 | 6 | PF00169 | |
| Domain | - | 1.40e-03 | 95 | 95 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.45e-03 | 44 | 95 | 3 | SM00282 | |
| Domain | Cadherin_CS | 2.32e-03 | 109 | 95 | 4 | IPR020894 | |
| Domain | HMG_box | 2.48e-03 | 53 | 95 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 2.62e-03 | 54 | 95 | 3 | PS50118 | |
| Domain | HMG | 2.62e-03 | 54 | 95 | 3 | SM00398 | |
| Domain | CADHERIN_1 | 2.65e-03 | 113 | 95 | 4 | PS00232 | |
| Domain | Cadherin | 2.65e-03 | 113 | 95 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.74e-03 | 114 | 95 | 4 | PS50268 | |
| Domain | - | 2.74e-03 | 114 | 95 | 4 | 2.60.40.60 | |
| Domain | - | 2.76e-03 | 55 | 95 | 3 | 1.10.30.10 | |
| Domain | CA | 2.82e-03 | 115 | 95 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.91e-03 | 116 | 95 | 4 | IPR015919 | |
| Domain | Post-SET_dom | 2.93e-03 | 16 | 95 | 2 | IPR003616 | |
| Domain | PostSET | 2.93e-03 | 16 | 95 | 2 | SM00508 | |
| Domain | POST_SET | 2.93e-03 | 16 | 95 | 2 | PS50868 | |
| Domain | PH | 2.96e-03 | 278 | 95 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 3.02e-03 | 279 | 95 | 6 | PS50003 | |
| Domain | PH_domain | 3.07e-03 | 280 | 95 | 6 | IPR001849 | |
| Domain | Cadherin | 3.10e-03 | 118 | 95 | 4 | IPR002126 | |
| Domain | Laminin_G | 3.21e-03 | 58 | 95 | 3 | IPR001791 | |
| Domain | HMG_box_dom | 4.43e-03 | 65 | 95 | 3 | IPR009071 | |
| Domain | Zinc_finger_PHD-type_CS | 4.43e-03 | 65 | 95 | 3 | IPR019786 | |
| Domain | PDZ | 5.83e-03 | 141 | 95 | 4 | PF00595 | |
| Domain | Spectrin | 6.04e-03 | 23 | 95 | 2 | PF00435 | |
| Domain | PHD | 6.61e-03 | 75 | 95 | 3 | PF00628 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.91e-05 | 32 | 71 | 4 | MM15326 | |
| Pubmed | 2.96e-10 | 5 | 98 | 4 | 15024750 | ||
| Pubmed | SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. | 2.06e-09 | 7 | 98 | 4 | 9115257 | |
| Pubmed | 2.06e-09 | 7 | 98 | 4 | 10527873 | ||
| Pubmed | DLGAP4 ZBTB43 SMARCAD1 CSDE1 UBR5 SETD5 CADPS NAV3 MACF1 PDZD2 LARGE1 | 2.22e-08 | 407 | 98 | 11 | 12693553 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 MAP2 NSD2 MYRIP EVC ATP9B FRYL ITFG1 CSDE1 TLK1 PTPN13 SHC2 INTS2 SETD5 EHMT1 MACF1 PHF14 RASSF3 PDZD2 | 3.07e-08 | 1489 | 98 | 19 | 28611215 |
| Pubmed | SART3 NSD2 SPTAN1 WDR46 FRYL CSDE1 NOP58 PBRM1 SBF1 UBR5 CPSF1 MACF1 | 3.24e-07 | 653 | 98 | 12 | 22586326 | |
| Pubmed | ERBB2 NSD2 FAT3 SMARCAD1 YY1 FAM83H SLC35G1 PBRM1 UBR5 SETD5 CADPS BRD9 EHMT1 MACF1 IRS2 | 5.44e-07 | 1116 | 98 | 15 | 31753913 | |
| Pubmed | SART3 NSD2 SMARCAD1 XRCC1 YY1 CSDE1 NOP58 PBRM1 UBR5 BRD9 EHMT1 CPSF1 PHF14 TARS1 | 9.85e-07 | 1014 | 98 | 14 | 32416067 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 19640847 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NSD2 SMARCAD1 XRCC1 YY1 SUV39H2 NOP58 PBRM1 BRD9 EHMT1 PHF14 TIMELESS | 1.21e-06 | 608 | 98 | 11 | 36089195 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.38e-06 | 281 | 98 | 8 | 28706196 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.51e-06 | 498 | 98 | 10 | 36634849 | |
| Pubmed | 3.70e-06 | 430 | 98 | 9 | 32581705 | ||
| Pubmed | ERBB2 COL11A1 KIF26B ZBTB43 XRCC1 SBF1 SVIL BRD9 POC5 PLEKHH2 SEZ6 | 4.01e-06 | 689 | 98 | 11 | 36543142 | |
| Pubmed | 4.43e-06 | 329 | 98 | 8 | 17474147 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 MAP2 KIF26B SPTAN1 FRYL FAM83H PTPN13 SBF1 SVIL SIK2 MACF1 IRS2 | 5.68e-06 | 861 | 98 | 12 | 36931259 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | MRPL23 ERBB2 DLGAP4 ATP9B FAM83H ITFG1 CSDE1 PTPN13 PBRM1 UBR5 MACF1 | 6.00e-06 | 719 | 98 | 11 | 35337019 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SPTAN1 WDR46 DVL3 GTPBP1 CSDE1 NOP58 PTPN13 SBF1 BRD9 EHMT1 MACF1 | 6.40e-06 | 724 | 98 | 11 | 36232890 |
| Pubmed | 7.42e-06 | 251 | 98 | 7 | 27507650 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23414593 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20025767 | ||
| Pubmed | Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. | 7.86e-06 | 2 | 98 | 2 | 17851532 | |
| Pubmed | Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. | 7.86e-06 | 2 | 98 | 2 | 17982484 | |
| Pubmed | The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. | 7.86e-06 | 2 | 98 | 2 | 1375324 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32543142 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23321250 | ||
| Pubmed | Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. | 7.86e-06 | 2 | 98 | 2 | 11420047 | |
| Pubmed | Independent regulation of the two Pax5 alleles during B-cell development. | 7.86e-06 | 2 | 98 | 2 | 10192389 | |
| Pubmed | SART3 DLGAP2 DLGAP1 MAP2 PCLO SPTAN1 DLGAP4 GTPBP1 CSDE1 DLGAP3 SBF1 CADPS SVIL MACF1 TARS1 | 1.13e-05 | 1431 | 98 | 15 | 37142655 | |
| Pubmed | 1.16e-05 | 496 | 98 | 9 | 31343991 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 SZT2 NSD2 FRYL SLC29A2 FAM83H TLK1 SBF1 SETD5 KLHL36 EHMT1 CPSF1 IRS2 | 1.38e-05 | 1105 | 98 | 13 | 35748872 |
| Pubmed | SART3 MRPL23 MAP2 SPTAN1 SMARCAD1 GRSF1 EHD4 NOP58 PTPN13 SBF1 UBR5 SIK2 EHMT1 MACF1 TARS1 | 1.76e-05 | 1487 | 98 | 15 | 33957083 | |
| Pubmed | SART3 DLGAP2 DLGAP1 MAP2 PCLO SPTAN1 DLGAP4 DVL3 CSDE1 DLGAP3 CADPS NAV3 MACF1 | 1.90e-05 | 1139 | 98 | 13 | 36417873 | |
| Pubmed | 2.01e-05 | 116 | 98 | 5 | 21549307 | ||
| Pubmed | 2.09e-05 | 197 | 98 | 6 | 36604605 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 2.35e-05 | 3 | 98 | 2 | 15744052 | |
| Pubmed | Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma. | 2.35e-05 | 3 | 98 | 2 | 27748274 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 17658281 | ||
| Pubmed | Interaction domains of neurofilament light chain and brain spectrin. | 2.35e-05 | 3 | 98 | 2 | 1902666 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 15870067 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 26811494 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 26792835 | ||
| Pubmed | Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma. | 2.35e-05 | 3 | 98 | 2 | 34099776 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 SPTAN1 WDR46 SMARCAD1 GRSF1 FAM83H EHD4 CSDE1 NOP58 SBF1 UBR5 CPSF1 MACF1 TARS1 | 2.62e-05 | 1353 | 98 | 14 | 29467282 |
| Pubmed | 3.60e-05 | 131 | 98 | 5 | 28634551 | ||
| Pubmed | ERBB2 ADAM18 KMT2E SUV39H2 CAPN11 TLK1 SETD5 EHMT1 IRS2 TARS1 | 4.15e-05 | 730 | 98 | 10 | 34857952 | |
| Pubmed | 4.40e-05 | 225 | 98 | 6 | 12168954 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 NSD2 PCLO SPTAN1 WDR46 SMARCAD1 GTPBP1 GRSF1 EHD4 NOP58 PBRM1 EHMT1 CPSF1 TARS1 | 4.61e-05 | 1425 | 98 | 14 | 30948266 |
| Pubmed | Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia. | 4.70e-05 | 4 | 98 | 2 | 26301816 | |
| Pubmed | Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes. | 4.70e-05 | 4 | 98 | 2 | 17513763 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 22279592 | ||
| Pubmed | Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2. | 4.70e-05 | 4 | 98 | 2 | 19561085 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 18552207 | ||
| Pubmed | OCAM regulates embryonic spinal cord stem cell proliferation by modulating ErbB2 receptor. | 4.70e-05 | 4 | 98 | 2 | 25875008 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 20498068 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 4.70e-05 | 4 | 98 | 2 | 18231586 | |
| Pubmed | 5.89e-05 | 347 | 98 | 7 | 17114649 | ||
| Pubmed | DLGAP1 CNKSR1 SPTAN1 ZBTB43 DVL3 MYRIP SMARCAD1 CSDE1 PTPN13 CADPS NAV3 MACF1 TARS1 | 6.56e-05 | 1285 | 98 | 13 | 35914814 | |
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 7.52e-05 | 29 | 98 | 3 | 19208628 | |
| Pubmed | SART3 NSD2 XRCC1 GRSF1 CSDE1 PTPN13 PBRM1 SBF1 INTS2 SETD5 BRD9 EHMT1 MACF1 PHF14 | 7.80e-05 | 1497 | 98 | 14 | 31527615 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 10521485 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 33347690 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 3027087 | ||
| Pubmed | DLGAP2 DLGAP1 SPTAN1 DLGAP4 DLGAP3 PBRM1 SBF1 UBR5 SVIL EHMT1 MACF1 | 8.66e-05 | 963 | 98 | 11 | 28671696 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.11e-04 | 33 | 98 | 3 | 22357600 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 25636086 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 20084102 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 23611113 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 23973221 | ||
| Pubmed | 1.29e-04 | 529 | 98 | 8 | 14621295 | ||
| Pubmed | 1.33e-04 | 35 | 98 | 3 | 33864728 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | WDR46 XRCC1 FAM83H EHD4 NOP58 PBRM1 UBR5 SVIL CPSF1 MACF1 TARS1 | 1.48e-04 | 1024 | 98 | 11 | 24711643 |
| Pubmed | Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. | 1.64e-04 | 7 | 98 | 2 | 16107726 | |
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 20937854 | ||
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 16059920 | ||
| Pubmed | MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. | 1.64e-04 | 7 | 98 | 2 | 20588255 | |
| Pubmed | DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. | 1.64e-04 | 7 | 98 | 2 | 9286858 | |
| Pubmed | 2.12e-04 | 103 | 98 | 4 | 32744500 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 17131403 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 32640256 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 2.29e-04 | 732 | 98 | 9 | 34732716 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 2.72e-04 | 110 | 98 | 4 | 37219487 | |
| Pubmed | 2.79e-04 | 9 | 98 | 2 | 16546096 | ||
| Pubmed | MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling. | 2.79e-04 | 9 | 98 | 2 | 25224226 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.45e-04 | 774 | 98 | 9 | 15302935 | |
| Pubmed | 3.48e-04 | 10 | 98 | 2 | 8001125 | ||
| Pubmed | 3.48e-04 | 10 | 98 | 2 | 23333759 | ||
| Pubmed | 3.64e-04 | 49 | 98 | 3 | 34368113 | ||
| Pubmed | 3.64e-04 | 332 | 98 | 6 | 37433992 | ||
| Pubmed | 3.64e-04 | 332 | 98 | 6 | 25693804 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 FAM83H CSDE1 TLK1 NOP58 PBRM1 UBR5 SVIL EHMT1 TIMELESS POC5 | 4.14e-04 | 1155 | 98 | 11 | 20360068 |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 4.25e-04 | 11 | 98 | 2 | 20351715 | |
| Pubmed | Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein. | 4.25e-04 | 11 | 98 | 2 | 10721728 | |
| Pubmed | 4.62e-04 | 486 | 98 | 7 | 20936779 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.09e-04 | 231 | 98 | 5 | 16452087 | |
| Pubmed | Identification of candidate proteins binding to prion protein. | 5.09e-04 | 12 | 98 | 2 | 9173930 | |
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 26687222 | ||
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 21402781 | ||
| Pubmed | 5.13e-04 | 130 | 98 | 4 | 12421765 | ||
| Pubmed | 5.13e-04 | 650 | 98 | 8 | 38777146 | ||
| Interaction | SHANK2 interactions | 7.04e-06 | 55 | 98 | 5 | int:SHANK2 | |
| Interaction | NUMA1 interactions | NSD2 DVL3 SMARCAD1 XRCC1 YY1 SUV39H2 CSDE1 PBRM1 EHMT1 MACF1 PHF14 | 1.75e-05 | 469 | 98 | 11 | int:NUMA1 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.92e-06 | 34 | 66 | 4 | 487 | |
| GeneFamily | PDZ domain containing | 1.92e-05 | 152 | 66 | 6 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.05e-04 | 206 | 66 | 6 | 682 | |
| GeneFamily | Cadherin related | 1.72e-03 | 17 | 66 | 2 | 24 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NPHS1 SOX11 COL11A1 MAP2 NSD2 FAT3 SPTAN1 DLGAP4 TMEM243 WDR46 MYRIP FRYL SMARCAD1 SUV39H2 GRSF1 ST6GAL2 TLK1 SETD5 CADPS EHMT1 PHF14 IRS2 PIK3R5 PIF1 | 6.41e-09 | 1370 | 96 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 181 | 98 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 181 | 98 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-07 | 185 | 98 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-07 | 185 | 98 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.83e-06 | 179 | 98 | 6 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.88e-06 | 189 | 98 | 6 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.24e-06 | 192 | 98 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-06 | 193 | 98 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-06 | 194 | 98 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.50e-06 | 194 | 98 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-06 | 196 | 98 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 198 | 98 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 198 | 98 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 198 | 98 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 198 | 98 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-06 | 200 | 98 | 6 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-06 | 200 | 98 | 6 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-06 | 200 | 98 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 161 | 98 | 5 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.15e-05 | 174 | 98 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.15e-05 | 174 | 98 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.15e-05 | 174 | 98 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.15e-05 | 174 | 98 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 174 | 98 | 5 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.15e-05 | 174 | 98 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 174 | 98 | 5 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.15e-05 | 174 | 98 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.15e-05 | 174 | 98 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 174 | 98 | 5 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.15e-05 | 174 | 98 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-05 | 175 | 98 | 5 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-05 | 177 | 98 | 5 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-05 | 179 | 98 | 5 | dc0b806904ef4c2f74f34ade2b1c0d6893f3b2ec | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.75e-05 | 179 | 98 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.75e-05 | 179 | 98 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 180 | 98 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-05 | 180 | 98 | 5 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 5.55e-05 | 185 | 98 | 5 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.84e-05 | 187 | 98 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.99e-05 | 188 | 98 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.99e-05 | 188 | 98 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 189 | 98 | 5 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 189 | 98 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 6.30e-05 | 190 | 98 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.45e-05 | 191 | 98 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.45e-05 | 191 | 98 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 192 | 98 | 5 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 192 | 98 | 5 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 192 | 98 | 5 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 192 | 98 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.78e-05 | 193 | 98 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Cortical_neuron|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.79e-05 | 36 | 98 | 3 | 25fd4cf19f2ed94f99600c18383b17f86bb17ef5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.95e-05 | 194 | 98 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.95e-05 | 194 | 98 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.95e-05 | 194 | 98 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-05 | 195 | 98 | 5 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.12e-05 | 195 | 98 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 195 | 98 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 195 | 98 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 7.29e-05 | 196 | 98 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 7.29e-05 | 196 | 98 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 196 | 98 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.29e-05 | 196 | 98 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.29e-05 | 196 | 98 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.65e-05 | 198 | 98 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 198 | 98 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 7.65e-05 | 198 | 98 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 198 | 98 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.65e-05 | 198 | 98 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 7.65e-05 | 198 | 98 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 7.83e-05 | 199 | 98 | 5 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 8.02e-05 | 200 | 98 | 5 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.02e-05 | 200 | 98 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 200 | 98 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 200 | 98 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.22e-04 | 115 | 98 | 4 | 0a37816898eaa18ae49d4d936e1a760f089e0ceb | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-04 | 121 | 98 | 4 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 125 | 98 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-04 | 128 | 98 | 4 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-04 | 131 | 98 | 4 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-04 | 140 | 98 | 4 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-04 | 143 | 98 | 4 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.89e-06 | 195 | 97 | 8 | 1545_UP | |
| Disease | Neurodevelopmental Disorders | 1.50e-05 | 93 | 98 | 5 | C1535926 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.16e-05 | 49 | 98 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | asphyxia neonatorum (biomarker_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:11088 (biomarker_via_orthology) | |
| Disease | neuroimaging measurement | SOX11 COL11A1 MAP2 SZT2 KIF26B FAT3 FRYL SMARCAD1 CADPS NAV3 MACF1 DMRT1 | 2.22e-04 | 1069 | 98 | 12 | EFO_0004346 |
| Disease | Childhood Medulloblastoma | 3.98e-04 | 43 | 98 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.98e-04 | 43 | 98 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 3.98e-04 | 43 | 98 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.98e-04 | 43 | 98 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.98e-04 | 43 | 98 | 3 | C0278876 | |
| Disease | Stomach Neoplasms | 4.79e-04 | 297 | 98 | 6 | C0038356 | |
| Disease | brain measurement, neuroimaging measurement | 5.02e-04 | 550 | 98 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Malignant neoplasm of stomach | 5.05e-04 | 300 | 98 | 6 | C0024623 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 5.89e-04 | 11 | 98 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | Medulloblastoma | 6.22e-04 | 50 | 98 | 3 | C0025149 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 6.22e-04 | 50 | 98 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 6.98e-04 | 52 | 98 | 3 | C0023452 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.39e-04 | 447 | 98 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 7.39e-04 | 447 | 98 | 7 | C3714756 | |
| Disease | Malignant neoplasm of breast | ERBB2 COL11A1 NSD2 SPTAN1 PCDHB15 DVL3 SUV39H2 PBRM1 EHMT1 MACF1 TIMELESS | 8.79e-04 | 1074 | 98 | 11 | C0006142 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.11e-03 | 61 | 98 | 3 | C1961102 | |
| Disease | Benign neoplasm of stomach | 1.44e-03 | 17 | 98 | 2 | C0153943 | |
| Disease | thrombomodulin measurement | 1.44e-03 | 17 | 98 | 2 | EFO_0007774 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.44e-03 | 17 | 98 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.44e-03 | 17 | 98 | 2 | C0154060 | |
| Disease | response to ketamine | 1.59e-03 | 69 | 98 | 3 | EFO_0009748 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.59e-03 | 69 | 98 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 2.20e-03 | 21 | 98 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Stomach Carcinoma | 2.20e-03 | 21 | 98 | 2 | C0699791 | |
| Disease | brain connectivity measurement | 2.21e-03 | 400 | 98 | 6 | EFO_0005210 | |
| Disease | Disease Exacerbation | 2.26e-03 | 165 | 98 | 4 | C0235874 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.87e-03 | 24 | 98 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.87e-03 | 24 | 98 | 2 | C3805278 | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.99e-03 | 293 | 98 | 5 | C1708349 | |
| Disease | medial orbital frontal cortex volume measurement | 3.12e-03 | 25 | 98 | 2 | EFO_0010315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSTFYRSLLEDDDMG | 1001 | P04626 | |
| GDTLGDSSSSVLEFM | 476 | Q9H8M2 | |
| DGMAFSIHSYEEGTD | 2576 | Q8IZF6 | |
| ISPDSMDYLGASESE | 1186 | Q8IUA7 | |
| SMRSDGTDNAYVADG | 586 | Q9Y3Q7 | |
| SDGTEYGLSEADMEA | 101 | O00178 | |
| GDVDSLELGDMVEYS | 551 | O75534 | |
| SYIKAMGDEDSGDSD | 346 | O14490 | |
| SSTESAQDAYMDGQG | 561 | O14490 | |
| SYIKAMGDEESGESD | 436 | Q9P1A6 | |
| GADPTIETDSGYNSM | 271 | Q9H9E1 | |
| YEALSGGSTMEGLED | 226 | Q9UMQ6 | |
| GGYDSSSTLMSSELE | 171 | Q92997 | |
| SGSYIKAMGDEDSDE | 366 | Q9Y2H0 | |
| MSSGYSSLEEDAEDF | 1 | Q86WH2 | |
| EDTMSSGDLLAATGD | 831 | P49796 | |
| MEYSSSGKATGEADV | 431 | Q12849 | |
| TTEYSAMASLAGGLD | 261 | Q02548 | |
| MAAIYDADNGSGTSE | 1051 | Q9ULU8 | |
| VSYSRGFTGEDEDMA | 1156 | O60500 | |
| RYDAFGEDSSSAMGV | 371 | Q9Y2X3 | |
| LGAGSAATAASEEMY | 456 | Q8NA72 | |
| YEEGESEAESITSFM | 366 | Q86U86 | |
| YSIGGSDDNIESMER | 496 | Q8N4N3 | |
| TYSMEEGTGDSENLR | 101 | O95461 | |
| ESLETMDGVYGSGEV | 56 | A6NFK2 | |
| LEDGADSMESLSYTP | 121 | Q8WWW8 | |
| GTVSYGADTMDEIQS | 486 | O43861 | |
| SGYESVMRDSEATGS | 1896 | Q2KJY2 | |
| DDEEEMLYGDSGSLF | 741 | Q10570 | |
| DYSDGMEEIFGSLNS | 1571 | P12107 | |
| GVAEDRDYMSDSEVS | 3826 | Q9Y6V0 | |
| GSTGEMSTVQELDYE | 2326 | Q9NYQ8 | |
| GDSTEPSLSSMYGDA | 1541 | O15018 | |
| MYGDAEDSSSDPESL | 1551 | O15018 | |
| SSDLDMSSEVDVGGY | 806 | Q8IVL0 | |
| SGGSYEEEKSDSMPL | 1536 | O94915 | |
| AAESLGEMAESSGVS | 366 | O96028 | |
| DSSYKNGSRDTGSMD | 1166 | Q9H0H0 | |
| TAETSYLEMAAGSEP | 11 | Q8IZD2 | |
| TTDSFIAVMYGETEG | 96 | Q9H223 | |
| TMSSYDLDIEASDGG | 311 | Q9Y5E8 | |
| YGVDGESDSIMSSAS | 351 | O94880 | |
| GSEMYLTASDDSSSI | 321 | Q8IVE3 | |
| QISDIYISGESGDMS | 181 | Q9UPN3 | |
| MAGSVAESYDTESGF | 801 | O95248 | |
| SLSSDTGDNGDYTEM | 1061 | Q9Y4H2 | |
| TKDAYMSSEDQASGG | 276 | P0C862 | |
| EATSLGSQSYEDMRG | 491 | P15391 | |
| GYTPEDTMDSGETAQ | 206 | Q5T197 | |
| DGEEEGTVLSYSSMV | 126 | A2RUQ5 | |
| SYIKAMGDEESGDSD | 396 | O95886 | |
| SEVAMSDYESVGELS | 4526 | Q8TDW7 | |
| DMTYHLKDESSSGGD | 311 | Q9UJ99 | |
| SNTEMSGAGDSEYIT | 281 | P57679 | |
| GSLLDVDMDGSSGTY | 81 | Q6ZRV2 | |
| EAGSEYTVVSMSDAG | 871 | D6RIA3 | |
| GVSESDGDEYAMASS | 61 | Q15020 | |
| DGDEYAMASSAESSP | 66 | Q15020 | |
| TAPGDSTGYMEVSLD | 471 | Q9H9B1 | |
| YSMALAADSASGEVG | 231 | Q9Y5R6 | |
| SDRGDSDMDEATYSS | 1316 | Q12923 | |
| MLSGIEAAAGEYEDS | 1 | Q9H611 | |
| DMYLEEGGVSSNDFS | 186 | P26639 | |
| MSSQGSVDSDHLGYD | 1856 | Q5T011 | |
| SGSSGEDADDLMFDL | 351 | P35716 | |
| SMASGVDAETSALGY | 181 | Q14542 | |
| EDSEYDSGSDVGSSL | 356 | Q9H4L7 | |
| SGMEKYGSFEEAEAS | 961 | O95425 | |
| SDYREDGMDLGSDAG | 21 | P0DPB3 | |
| DDSSFIEISYDAMGE | 441 | Q5QGS0 | |
| YSDMAAGSDPESVEA | 16 | Q9C0A6 | |
| DSPSLDSVDSEYDMG | 506 | Q9H0K1 | |
| LEEGDDGDRLYSSMS | 186 | Q96JF0 | |
| SDEGGAASDDSMTDL | 156 | Q15527 | |
| ELDGFEGEASSTSMI | 6 | Q8IZR5 | |
| FGSLTDSSEEALEGM | 566 | Q969H4 | |
| DFYGSSMEEFSGERS | 316 | O43298 | |
| YGTVDMTTGIEADES | 511 | Q8TBB6 | |
| MEDFATRTYGTSGLD | 1 | Q9BU79 | |
| REMTEGYGSLDDRSS | 801 | Q9UNS1 | |
| TDFGLSKIMDDDSYG | 606 | Q9UKI8 | |
| DGEELDGSDMSAIIY | 426 | Q96CK0 | |
| SGLSDGMDSGYVEDS | 381 | Q8WYR1 | |
| SFASGGDTDMTDYVA | 251 | P98077 | |
| TYLLDGSCMVEESGT | 2226 | Q13813 | |
| DYQMKGSGDISSDSI | 371 | Q9H5I1 | |
| MASGDTLYIATDGSE | 1 | P25490 | |
| ESPEGSAADDLYSML | 116 | Q16540 | |
| MEAGEVSSLGETYDF | 281 | Q9Y6L7 | |
| TDSSGAAAGMALRYE | 511 | Q53EL9 | |
| LVGYSSSGSEDESED | 6 | Q9BQ65 | |
| AVDSTGTYMATSGLD | 366 | O15213 | |
| ILTNTSGSMDEGDDY | 731 | P11137 | |
| SGSMDEGDDYLPATT | 736 | P11137 | |
| YLMAGPGSSSEEDEA | 401 | P18887 | |
| LFGSDTSGMEESYSG | 206 | Q2M3R5 | |
| TSVVPGDYDGDSQMD | 101 | Q8TB96 | |
| DGSDSFVMLLESESG | 1126 | Q6BDS2 | |
| DTASESYLPGEDLMS | 236 | O95071 | |
| GTDDRSDFGETLSAM | 246 | O00160 | |
| GMDDLGIYSCDVTDT | 1201 | P52179 | |
| EVASSVASAYDEMGS | 381 | Q8NFW9 |